|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_ocn908076078 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
150509s2004 pau o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d ZCU
|d MERUC
|d ICG
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DKC
|d AU@
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 923525049
|a 929496247
|
| 020 |
|
|
|a 9781469876443
|
| 020 |
|
|
|a 1469876442
|
| 029 |
1 |
|
|a DEBBG
|b BV044074194
|
| 035 |
|
|
|a (OCoLC)908076078
|z (OCoLC)923525049
|z (OCoLC)929496247
|
| 050 |
|
4 |
|a RC692 .F384 2004
|
| 082 |
0 |
4 |
|a 616.13
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Fuster, Valentin.
|
| 245 |
1 |
0 |
|a Atherothrombosis and Coronary Artery Disease.
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Philadelphia :
|b Wolters Kluwer Health,
|c 2004.
|
| 300 |
|
|
|a 1 online resource (1676 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Atherothrombosis and Coronary Artery Disease; Contents; Contributors; PREFACE; Introduction; A Historical Perspective on Atherosclerosis and Coronary Artery Disease; Prevalence, Incidence, and Mortality of Coronary Heart Disease; PART I Major Risk Factors and Primary Prevention; Overview; Lipid Abnormalities; Nutrition, Lipid Disorders, and the Metabolic Syndrome; Genetic Dyslipoproteinemias; Structure and Function of the Plasma Lipoproteins and Their Receptors; Plasma High-Density Lipoproteins and Atherogenesis; Lipoprotein Oxidation, Arterial Inflammation, and Atherogenesis; Lipoprotein(a).
|
| 505 |
8 |
|
|a Clinical Classifications of Lipid AbnormalitiesManagement and Adult Treatment Panel III Guidelines; Impact of Management on Stabilization of Plaque and Reduction of Cardiovascular Events; Hypertension, Cigarette Smoking, Diabetes, Obesity, and Others; Hypertension Genetics and Mechanisms; Role of Angiotensin in the Pathobiology of Cardiovascular Disease; Clinical Classifications of Hypertensive Diseases; Management of Hypertension; Hypertensive Heart Disease; Smoking and Atherothrombosis; Diabetes, Obesity, and the Metabolic Syndrome; Estrogen and Atherothrombosis.
|
| 505 |
8 |
|
|a Vitamins in Coronary Artery DiseaseII Pathogenesis of Atherothrombosis; General Principles; Developmental Biology of the Vasculature; Molecular Basis of Vasculogenesis, Angiogenesis, and Arteriogenesis; Embryogenesis of the Vascular System; Mouse Models of Lipoprotein Disorders and Atherosclerosis; Genetics of Atherothrombotic Disease; The Normal Artery; Vascular Endothelium; Role of Alterations in the Differentiated State of the Smooth Muscle Cell in Atherothrombogenesis; The Vascular Extracellular Matrix; The Lesions of Atherothrombosis.
|
| 505 |
8 |
|
|a Histologic Classification of Human Atherosclerotic LesionsPathogenesis of Atherothrombosis; Atherothrombosis in Youth; Coronary Thrombosis -- Local and Systemic Factors; Special Pathogenetic Factors; Leukocytes, Adhesion Molecules, and Chemokines in Atherothrombosis; The Role of Macrophages; The Role of Lymphocyte; Viral Activation and Causation of Atherothrombosis and Thrombosis; Cytokines and Growth Regulatory Molecules; The Role of Rheology in Atherothrombotic Coronary Artery Disease; Interaction of Platelet Activation and Coagulation; Interaction of Platelet Activation and Thrombosis.
|
| 505 |
8 |
|
|a Coronary Spasm and AtherothrombosisTransplant Arteriosclerosis; Vascular Grafts and Their Sequelae; Genomics and Gene Transfer; Nonatherothrombotic Coronary Artery Disease; The Microcirculation in Atherothrombotic Coronary Artery Disease; III Markers and Evolving Imaging of Atherothrombotic Disease; Inflammatory Markers; Evolving Invasive and Noninvasive Imaging Techniques in Atherothrombotic Disease; Endovascular Assessment of the High-Risk Plaque; Computed Tomography of the Heart; Magnetic Resonance Imaging of the Heart in Coronary Artery Disease; Noninvasive Imaging of the Vascular System.
|
| 500 |
|
|
|a IV Acute Coronary Syndromes.
|
| 500 |
|
|
|a Written by the world's foremost authorities, this volume provides comprehensive coverage of current approaches to the prevention, diagnosis, and management of atherothrombosis and its coronary and noncoronary complications. This edition has been thoroughly updated, sharply focused on clinical information, and trimmed to one manageable volume. Coverage begins with a review of risk factors and prevention, emphasizing lipid abnormalities, hypertension, smoking, diabetes, and obesity. Subsequent sections examine the pathogenesis of atherosclerosis, markers and imaging, acute coronary syndromes, ch.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Atherosclerosis.
|
| 650 |
|
0 |
|a Coronary heart disease.
|
| 650 |
|
6 |
|a Athérosclérose.
|
| 650 |
|
7 |
|a Atherosclerosis
|2 fast
|
| 650 |
|
7 |
|a Coronary heart disease
|2 fast
|
| 700 |
1 |
|
|a Topol, Eric J.
|
| 700 |
1 |
|
|a Nabel, Elizabeth G.
|
| 776 |
0 |
8 |
|i Print version:
|a Fuster, Valentin.
|t Atherothrombosis and Coronary Artery Disease.
|d Philadelphia : Wolters Kluwer Health, ©2004
|z 9780781735834
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=2032576
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL2032576
|
| 994 |
|
|
|a 92
|b IZTAP
|
